Search research articles
Contact Us
Filters
Showing results (101-110 of 131) with videos related to
Page
of 14
Sort By:
Annals of the Rheumatic Diseases
|
November 3, 2022
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
George E Fragoulis, Elena Nikiphorou, Mrinalini Dey, et al.
Annals of the Rheumatic Diseases
|
March 26, 2022
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases
Lianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, et al.
Annals of the Rheumatic Diseases
|
May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry
Bayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Annals of the Rheumatic Diseases
|
May 31, 2020
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries
Romain Aymon, Denis Mongin, Romain Guemara, et al.
Annals of the Rheumatic Diseases
|
December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases
|
June 15, 2022
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration
Kim Lauper, Michele Iudici, Denis Mongin, et al.
Annals of the Rheumatic Diseases
|
January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
Frontiers in Medicine
|
March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries
Rebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
ACR Open Rheumatology
|
August 24, 2022
Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
Kanon Jatuworapruk, Anna Montgomery, Milena Gianfrancesco, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 131) with videos related to
Sort By:
Page
of 14
Annals of the Rheumatic Diseases
|
November 3, 2022
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
George E Fragoulis, Elena Nikiphorou, Mrinalini Dey, et al.
Annals of the Rheumatic Diseases
|
March 26, 2022
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases
Lianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, et al.
Annals of the Rheumatic Diseases
|
May 30, 2024
Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry
Bayram Farisogullari, Saskia Lawson-Tovey, Kimme L Hyrich, et al.
Annals of the Rheumatic Diseases
|
May 31, 2020
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 15, 2025
Incidence of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis Treated With JAK Inhibitors Compared With Biologic Disease-Modifying Antirheumatic Drugs: Data From an International Collaboration of Registries
Romain Aymon, Denis Mongin, Romain Guemara, et al.
Annals of the Rheumatic Diseases
|
December 10, 2023
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
Romain Aymon, Denis Mongin, Sytske Anne Bergstra, et al.
Annals of the Rheumatic Diseases
|
June 15, 2022
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration
Kim Lauper, Michele Iudici, Denis Mongin, et al.
Annals of the Rheumatic Diseases
|
January 1, 2022
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Pedro M Machado, Saskia Lawson-Tovey, Anja Strangfeld, et al.
Frontiers in Medicine
|
March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registries
Rebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
ACR Open Rheumatology
|
August 24, 2022
Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry
Kanon Jatuworapruk, Anna Montgomery, Milena Gianfrancesco, et al.
Page
of 14